rs786200899
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_203486.3(DLL3):c.599_603dupGCGGT(p.Pro202fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000828 in 1,485,052 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000085 ( 0 hom. )
Consequence
DLL3
NM_203486.3 frameshift
NM_203486.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.785
Genes affected
DLL3 (HGNC:2909): (delta like canonical Notch ligand 3) This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-39502998-C-CGCGGT is Pathogenic according to our data. Variant chr19-39502998-C-CGCGGT is described in ClinVar as [Pathogenic]. Clinvar id is 6828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLL3 | NM_203486.3 | c.599_603dupGCGGT | p.Pro202fs | frameshift_variant | 4/9 | ENST00000356433.10 | NP_982353.1 | |
DLL3 | NM_016941.4 | c.599_603dupGCGGT | p.Pro202fs | frameshift_variant | 4/8 | NP_058637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLL3 | ENST00000356433.10 | c.599_603dupGCGGT | p.Pro202fs | frameshift_variant | 4/9 | 2 | NM_203486.3 | ENSP00000348810.4 | ||
DLL3 | ENST00000205143.4 | c.599_603dupGCGGT | p.Pro202fs | frameshift_variant | 4/8 | 1 | ENSP00000205143.3 | |||
DLL3 | ENST00000600437.1 | n.679_683dupGCGGT | non_coding_transcript_exon_variant | 4/6 | 1 | |||||
DLL3 | ENST00000596614.5 | c.409+2332_409+2336dupGCGGT | intron_variant | 2 | ENSP00000471688.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152018Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000596 AC: 5AN: 83876Hom.: 0 AF XY: 0.0000630 AC XY: 3AN XY: 47600
GnomAD3 exomes
AF:
AC:
5
AN:
83876
Hom.:
AF XY:
AC XY:
3
AN XY:
47600
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000848 AC: 113AN: 1333034Hom.: 0 Cov.: 33 AF XY: 0.0000913 AC XY: 60AN XY: 657036
GnomAD4 exome
AF:
AC:
113
AN:
1333034
Hom.:
Cov.:
33
AF XY:
AC XY:
60
AN XY:
657036
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74218
GnomAD4 genome
AF:
AC:
10
AN:
152018
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74218
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spondylocostal dysostosis 1, autosomal recessive Pathogenic:5
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2000 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 09, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 16, 2018 | Variant summary: DLL3 c.599_603dupGCGGT (p.Pro202AlafsX41) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 7.1e-05 in 113278 control chromosomes (gnomAD and publications).The variant, c.599_603dupGCGGT, has been reported in the literature in one consanguineous family in multiple homozygotes affected with Spondylocostal dysostosis 1 and in one heterozygote with a milder phenotype (Bulman_2000). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 04, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The observed frameshift c.599_603dup(p.Pro202AlafsTer41) variant in DLL3 gene has been reported previously in homozygous state in individual(s) affected with spondylocostal dysostosis 1 (Maddirevula S, et al., 2018; Bulman MP, et al., 2000). The p.Pro202AlafsTer41 variant has been reported with allele frequency of 0.006% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Pathogenic (multiple submissions). This variant causes a frameshift starting with codon Proline 202, changes this amino acid to Alanine residue, and creates a premature Stop codon at position 41 of the new reading frame, denoted p.Pro202AlafsTer41. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants in DLL3 gene have been previously reported to be pathogenic (Turnpenny PD, et al., 2003). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 03, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 10742114, 29620724, 31589614, 35137400, 14708096, 12746394) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change creates a premature translational stop signal (p.Pro202Alafs*41) in the DLL3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLL3 are known to be pathogenic (PMID: 12746394). This variant is present in population databases (rs750107624, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with spondylocostal dysostosis (PMID: 10742114, 29620724). ClinVar contains an entry for this variant (Variation ID: 6828). For these reasons, this variant has been classified as Pathogenic. - |
Leukodystrophy and acquired microcephaly with or without dystonia; Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at